When is TDOC's latest earnings report released?
The most recent financial report for Teladoc health, inc. (TDOC) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating TDOC's short-term business performance and financial health. For the latest updates on TDOC's earnings releases, visit this page regularly.
What is the operating profit of TDOC?
According to the latest financial report, Teladoc health, inc. (TDOC) reported an Operating Profit of -36M with an Operating Margin of -5.6% this period, representing a growth of 25.34% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is TDOC's revenue growth?
In the latest financial report, Teladoc health, inc. (TDOC) announced revenue of 642.27M, with a Year-Over-Year growth rate of 0.28%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much cash does TDOC have?
At the end of the period, Teladoc health, inc. (TDOC) held Total Cash and Cash Equivalents of 781.08M, accounting for 0.27 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does TDOC go with three margins increasing?
In the latest report, Teladoc health, inc. (TDOC) did not achieve the “three margins increasing” benchmark, with a gross margin of 69.3%%, operating margin of -5.6%%, and net margin of -3.9%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess TDOC's profit trajectory and future growth potential.
Is TDOC's EPS continuing to grow?
According to the past four quarterly reports, Teladoc health, inc. (TDOC)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.14. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of TDOC?
Teladoc health, inc. (TDOC)'s Free Cash Flow (FCF) for the period is 53.42M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 5.04% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of TDOC?
The latest valuation data shows Teladoc health, inc. (TDOC) has a Price-To-Earnings (PE) ratio of -4.76 and a Price/Earnings-To-Growth (PEG) ratio of 0.25. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.
